In this episode we look at the extensive research on the benefits and risks of GLP-1s based on a study of almost 2 million patients.  

A groundbreaking study published in the respected science journal Nature. The research explored how GLP-1 receptor agonists (like Ozempic and Wegovy) impact 175 health conditions.

• Total Participants: 1,955,135 individuals
• Follow-up Period: Median of 3.68 years (range: 2.05-5.37 years)
• Total Study Duration: 7,239,854 person-years
• Key Objective: Systematically examine associations between GLP-1 receptor agonist use and 175 health outcomes

Picture this: a team of dedicated researchers tracking nearly two million people over several years. To put this into perspective, most medical studies might include a few thousand participants. This study represents the gold standard: large-scale, long-term and rigorously documented.

The results show that GLP-1 medications can help with many health problems, from heart disease to mental health. However, the study also points out some risks, especially with gastrointestinal issues and kidney health.

Though there are still risks to consider, this research shows how far we’ve come in understanding and improving health. We still have challenges to face, but it highlights how much we can achieve when we truly understand our bodies.

Read our companion blog post on this episode

This episode provides a comprehensive guide on navigating the complexities of obtaining insurance coverage for the medication Zepbound. 

Zepbound is a GLP-1 weight loss medication made by Eli Lilly

We outline the steps involved with both private insurance and Medicaid, explaining key terms like prior authorization (PA), deductibles, and copays. The texts emphasize the importance of documenting weight-related comorbidities and the recent FDA approval of Zepbound for obstructive sleep apnea (OSA) as factors that can increase the likelihood of coverage, particularly with Medicare. Furthermore, they detail the appeal process for denials and offer cost-saving strategies, including manufacturer savings cards and patient assistance programs.

We have a companion blog post with all the details for this episode on getting Zepbound insurance coverage here on the GLP-1 Tribe web site.

https://www.glp-1tribe.com/how-to-get-zepbound-covered-by-insurance-and-save-money/

This podcast offers a comprehensive guide to using GLP-1 medications like Wegovy and Zepbound for weight management, highlighting that these injectable drugs are adjuncts to diet and exercise, not standalone solutions.

In this podcast we detail the gradual dose escalation schedules ("start low, go slow") designed to improve tolerability and minimize common gastrointestinal side effects as the body adjusts to the medication. They emphasize that the initial doses are primarily for acclimatization and that reaching the full therapeutic effect requires patience over several months. 

This episode reviews alternative strategies some healthcare providers use with patients.

Crucially, this episode underscores  the importance of long-term use for sustained weight management, as stopping the medication often leads to weight regain, and stress the need for a strong partnership with a healthcare provider to tailor dosing based on individual response, tolerability, and overall health.

Our companion detailed blog post for this episode is here - https://www.glp-1tribe.com/the-patients-guide-to-glp-1-weight-loss-medications-understanding-dosages-side-effects-and-strategies-for-wegovy-and-zepbound/

We tackle the question in this episode if switching GLP-1 medicines can help patients beat the weight loss stall and lose more weight. 

This episode discusses reasons for switching medications, such as weight loss plateaus, and details the typical process under medical supervision. Furthermore, it emphasizes the crucial role of lifestyle modifications for successful and sustained weight management and addresses long-term maintenance, potential side effects, cost considerations, and insurance coverage for these medications.

We have a detailed companion blog post on this topic - https://www.glp-1tribe.com/switching-your-weight-loss-injection-a-guide-to-moving-from-wegovy-or-ozempic-to-zepbound/

This is the official podcast of GLP-1 Tribe.  Find all the best resources about GLP-1 on the GLP-1 Tribe web site.
https://glp1tribe.com/

In this episode we discuss the ideal GLP-1 diet and how to eat well while on Wegovy, Ozempic, or Zepbound and get the best weight loss results.  

Check out these free GLP-1 resources for eating well

GLP-1 Optimized Recipe Creator - Create GLP1 optimized recipes in real time

GLP-1 Weekly Meal Planner - Create an entire week o GLP-1 meals - and the shopping list for all those meals in just seconds!

The GLP-1 Recipe Library is hundreds of optimized recipes you can browse for inspiration on your journey

Why Keeping Muscle Matters More Than You Think!

This podcast offers guidance on integrating strength training while on a weight loss journey that utilizes GLP-1 medications like Ozempic, Zepbound and Wegovy.

We highlight the tendency for individuals on these medications to lose muscle mass alongside fat and emphasize the critical role of strength training and adequate protein intake in preserving and building muscle. The podcast provides  practical advice for beginners on how to start strength training, including exercise examples, recommended routines, and strategies for managing potential GLP-1 side effects to maintain an active lifestyle.

Ultimately, we advocate for a comprehensive approach that combines medication with exercise and proper nutrition to achieve healthy and sustainable weight loss while improving body composition and overall well-being.

We have a free and comprehensive blog post article on this topic as well.

This is the official podcast of GLP-1 Tribe.  Find all the best resources about GLP-1 on the GLP-1 Tribe web site.
https://glp1tribe.com/

GLP-1 receptor agonist medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, initially developed for diabetes, offer substantial health benefits extending beyond weight loss. These "non-scale victories" include improvements in cardiovascular health, such as blood pressure and cholesterol, reduced inflammation, and better metabolic markers like blood sugar control. Patients also experience enhanced physical well-being, with increased mobility, less joint pain, and improved sleep, and report psychological benefits like increased energy and better mood, leading to a higher overall quality of life. While these medications share core mechanisms, newer dual-agonists like tirzepatide (Mounjaro/Zepbound) may provide more pronounced effects on weight and related health parameters, highlighting a holistic approach to improved health.

Read our while blog post on this topic

This is the official podcast of GLP1 Tribe

This episode explores the multifaceted experience of individuals using GLP-1 medications for weight loss, addressing the significant physical and internal changes that occur.

We highlight the common challenge of navigating social conversations about this visible transformation, focusing on the societal stigma surrounding weight loss drugs and the misconception of them being an "easy way out."  Or even worse "why dn't you jus diet and exercise"

The episode emphasizes the importance of personal autonomy in deciding what and when to share, offering strategies for crafting empowering narratives that focus on overall health rather than just weight.

Furthermore, it underscores the necessity of setting healthy boundaries to protect one's emotional well-being and shares personal experiences to provide validation and practical insights for people who need to have these tough conversations.  

This is the official podcast of GLP-1 Tribe.  Find all the best resources about GLP-1 on the GLP-1 Tribe web site.
https://glp1tribe.com/

The podcast explain that weight loss plateaus are a common occurrence for individuals using GLP-1 medications like Wegovy and Zepbound.  But there is a way to continue to get great progress and results.   

These medications, which mimic gut hormones to suppress appetite and slow digestion, initially lead to significant weight loss, but the body adapts over time, causing progress to stall. The podcast discuss physiological reasons for plateaus, such as metabolic adaptation and hormonal shifts, as well as behavioral and lifestyle factors, including dietary changes, reduced physical activity, stress, and sleep. To overcome these plateaus, the podcast suggests practical strategies to overcome the stall. 

This is the official podcast of GLP-1 Tribe.  Find all the best resources about GLP-1 on the GLP-1 Tribe web site.
https://glp1tribe.com/

This episode offers guidance on maximizing weight loss while using the medications Wegovy and Zepbound. It highlights that while these GLP-1 receptor agonists are effective for weight reduction, individual results vary. The article presents ten evidence-based strategies focusing on diet, hydration, exercise (both cardio and strength training), sleep, stress management, and consistent communication with healthcare providers. These recommendations aim to help individuals exceed average weight loss outcomes and promote long-term success. Furthermore, the text emphasizes the importance of integrating these medications with comprehensive lifestyle changes for optimal and sustained results.